How Not to Study a Disease
Autor Karl Herrupen Limba Engleză Paperback – 7 mar 2023
Preț: 99.71 lei
Preț vechi: 121.07 lei
-18% Nou
Puncte Express: 150
Preț estimativ în valută:
19.08€ • 19.87$ • 16.13£
19.08€ • 19.87$ • 16.13£
Carte disponibilă
Livrare economică 17-24 februarie
Livrare express 31 ianuarie-06 februarie pentru 39.21 lei
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780262546010
ISBN-10: 0262546019
Pagini: 272
Ilustrații: 28 b&w illustrations
Dimensiuni: 140 x 218 x 20 mm
Greutate: 0.36 kg
Editura: PENGUIN RANDOM HOUSE LLC
ISBN-10: 0262546019
Pagini: 272
Ilustrații: 28 b&w illustrations
Dimensiuni: 140 x 218 x 20 mm
Greutate: 0.36 kg
Editura: PENGUIN RANDOM HOUSE LLC
Notă biografică
Karl Herrup
Cuprins
Prologue ix
I In the Beginning 1
1 A Layperson's History of Alzheimer's Disease 3
2 A Physician's History of Alzheimer's Disease 23
3 A Scientist's History of Alzheimer's Disease 33
4 Mystery Solved! How Four Discoveries Transformed an Entire Field 53
II What Happened to our Cure? 71
5 Building a Model of Alzheimer's Disease 73
III Double-Edged Swords 97
6 Federal Support of Basic Biomedical Research 99
7 The Pharmaceutical and Biotech Industry 115
8 Testing Our Models: Breaking Bad 131
9 What is Alzheimer's Disease? 149
IV Where Shall We Go From Here? 169
10 A Layperson's Guide to the Biology of Aging 171
11 Building a New Model of Alzheimer's Disease 187
12 Rebalancing our Research Portfolio 207
13 Rebalancing our Institutions 227
14 Final Thoughts 243
Acknowledgments 247
Notes 249
Index 255
I In the Beginning 1
1 A Layperson's History of Alzheimer's Disease 3
2 A Physician's History of Alzheimer's Disease 23
3 A Scientist's History of Alzheimer's Disease 33
4 Mystery Solved! How Four Discoveries Transformed an Entire Field 53
II What Happened to our Cure? 71
5 Building a Model of Alzheimer's Disease 73
III Double-Edged Swords 97
6 Federal Support of Basic Biomedical Research 99
7 The Pharmaceutical and Biotech Industry 115
8 Testing Our Models: Breaking Bad 131
9 What is Alzheimer's Disease? 149
IV Where Shall We Go From Here? 169
10 A Layperson's Guide to the Biology of Aging 171
11 Building a New Model of Alzheimer's Disease 187
12 Rebalancing our Research Portfolio 207
13 Rebalancing our Institutions 227
14 Final Thoughts 243
Acknowledgments 247
Notes 249
Index 255